1. Home
  2. SPRY vs BAK Comparison

SPRY vs BAK Comparison

Compare SPRY & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$3.05

Market Cap

400.8M

Sector

Health Care

ML Signal

N/A

Logo Braskem SA ADR

BAK

Braskem SA ADR

N/A

Current Price

$1.11

Market Cap

474.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRY
BAK
Founded
2015
1972
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
400.8M
474.2M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
SPRY
BAK
Price
$3.05
$1.11
Analyst Decision
Strong Buy
Sell
Analyst Count
4
6
Target Price
★ $24.33
$1.66
AVG Volume (30 Days)
1.6M
★ 3.3M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $84,278,000.00
N/A
Revenue This Year
$52.57
$6.94
Revenue Next Year
$45.52
$3.27
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.91
$0.92
52 Week High
$13.15
$5.40

Technical Indicators

Market Signals
Indicator
SPRY
BAK
Relative Strength Index (RSI) 26.39 34.53
Support Level N/A $0.92
Resistance Level $4.55 $1.89
Average True Range (ATR) 0.28 0.13
MACD -0.08 -0.05
Stochastic Oscillator 8.82 24.73

Price Performance

Historical Comparison
SPRY
BAK

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

Share on Social Networks: